Tech Company Financing Transactions

T2 Biosystems Funding Round

On 10/17/2008, T2 Biosystems received $10.8 million in Series B investment from Flagship Pioneering, Flybridge Capital Partners and In-Q-Tel.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

101 Hartwell Ave.
Lexington, MA 02421
USA

Phone

(781) 457-1200

Website

www.t2biosystems.com

Email Address

[email protected]

Overview

T2 Biosystems (NASDAQ: TTOO) is a diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John McDonough

        

Chief Financial Officer

John Sprague

        

Chief Scientific Officer

Thomas Lowery

        

VP - General Counsel

Michael Gibbs

        

VP - Human Resources

Kelley Morgan

        

VP - Operations

Alec Barclay

        

VP - Regulatory Affairs

Sandy Estrada

        

Browse more venture capital transactions:

Prev: 10/17/2008: Cohera Medical venture capital transaction
Next: 10/17/2008: Renal CarePartners venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary